References

medecol

Медицина и экология

Medicine and ecology

2305-60452305-6053

Карагандинский медицинский университет

medecol-211

Research Article

ОБЗОРЫ ЛИТЕРАТУРЫ

LITERATURE REVIEWS

САРКОИДОЗ: ПРЕДИКТОРЫ ЗАБОЛЕВАЕМОСТИ И РАСПРОСТРАНЕННОСТИ

SARCOIDOSIS: PREDICTORS OF INCIDENCE AND PREVALENCE

Есенгельдинова

М. А.

Yessengeidinova

M. A.

noemail@neicon.ru

Медицинский университет АстанаКазахстанAstana Medical UniversityKazakhstan

2020

07092021

033341

2021

Есенгельдинова М.А.

Yessengeidinova M.A.

Данная работа распространяется под лицензией Creative Commons Attribution 4.0.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://medecol.qmu.kz/jour/article/view/211

В обзоре представлен анализ рандомизированных исследований, современные взгляды на проблему распространенности и заболеваемости саркоидозом. Эпидемиология саркоидоза и его клинические проявления сильно различаются по географическим регионам, различным этническим и возрастным группам, а также по полу. Проведена оценка воздействия социального статуса, профессиональных факторов, курения, сезонных вариаций. Изучены связь развития болезни с ожирением и прибавкой в весе, влияние инфекционных агентов. Проанализированы данные геномных исследований и наличие семейного саркоидоза.

An analysis of randomized trials, and current views on the problem of the prevalence and incidence of sarcoidosis are presented in the review. The epidemiology of sarcoidosis and its clinical manifestations significantly vary depending on geographical regions, various ethnic and age groups, gender. The impact of social status, occupational factors, smoking, seasonal variations was analyzed. The connection between the development of the disease with obesity and gaining of weight, as well as influence by infectious agents was studied. The data of genomic studies and history of sarcoidosis in the family were assessed.

саркоидозраспространенностьзаболеваемостьполвозрастгеныпрофессиональное воздействиесезонностькурениесемейный саркоидоз

sarcoidosisprevalenceincidencegenderagegenesoccupational exposureseasonalitysmokingfamilial sarcoidosis

References1

Диагностика и лечение саркоидоза: Федеральные согласительные клинические рекомендации. - М., 2014. - С. 1-45.

Саркоидоз: Клинич. рекомендации. -М., 2019. - 49 с.

Arkema E. V. Sarcoidosis incidence and prevalence: A nationwide register-based assessment in Sweden //Eur. Respir. J. - 2016. - V. 48, №6. - P. 1690-1699.

Baughman R. P. A Concise Review of Pulmonary Sarcoidosis /R. P. Baughman, D. A. Culver, M. A. Judson //Am. J. Respir. Crit. Care Med. - 2011. - V. 183, №5. - P. 573-581.

Baughman R. P. Sarcoidosis in America. Analysis Based on Health Care Use //Ann. Am. Thorac. Soc. - 2016. - Т. 13, №8. - P. 1244-1252.

Brito-Zeron P. Epidemiologic patterns of disease expression in sarcoidosis: age, gender and ethnicity-related differences //Clin. Exp. Rheumatol. - 2016. - V. 34, №3. - P. 380-388.

Chen E. S. Etiologies of Sarcoidosis /E. S. Chen, D. R. Moller //Clin. Rev. Allergy Immunol. - 2015. - V. 49, №1. - P. 6-18.

Cozier Y. C. Obesity and Weight Gain in Relation to Incidence of Sarcoidosis in US Black Women //Chest. - 2015. - V. 147, №4. - P. 1086-1093.

Cozier Y. C. Reproductive and hormonal factors in relation to incidence of sarcoidosis in US Black women: The Black Women's Health Study //Am. J. Epidemiol. - 2012. - V. 176, №7. - P. 635-641.

Cozier Y. C. Sarcoidosis: An Ill-afforded Disease /Y. C. Cozier, P. Govender //Am. J. Respir. Crit. Care Med. - 2020. - V. 201, №8. -P. 890-891.

Duchemann B. Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris //Eur. Respir. J. - 2017. -V. 50, №2. - P. 160-169.

Dumas O. Epidemiology of Sarcoidosis in a Prospective Cohort Study of U.S. Women //Ann. Am. Thorac. Soc. - 2016. - V. 13. №1. - P. 67-71.

Dumas O. Prospective study of body mass index and risk of sarcoidosis in US women // Eur. Respir. J. - 2017. - V. 50, №4. - P. 170-179.

Durmus Kocak N. Analysis of Age Distribution and Disease Presentation of 1269 Patients with Sarcoidosis //Eurasian J. Med. - 2017. - V. 49, №3. - P. 161-166.

Esteves T. Is there any association between Sarcoidosis and infectious agents?: A systematic review and meta-analysis /T. Esteves, G. Aparicio, V. Garcia-Patos //BMC Pulm. - Med. -2016. - V. 16, №1. - P. 165.

Fidler L. M. Epidemiology and health outcomes of sarcoidosis in a universal healthcare population: a cohort study //Eur. Respir. J. -2019. - V. 54, №4. - P. 1-9.

Gerke A. K. An analysis of seasonality of sarcoidosis in the United States veteran population: 2000-2007 //Sarcoidosis Vasc. Diffus. Lung Dis. - 2012. - V. 29, №2. - P. 155-158.

Gorham E. D. Trends and occupational associations in incidence of hospitalized pulmonary sarcoidosis and other lung diseases in Navy personnel: A 27-year historical prospective study, 1975-2001 //Chest. - 2004. - V. 126, №5. - P. 1431-1438.

Grunewald J. HLA associations and Lofgren's syndrome //Expert Rev. Clin. Immunol. -2012. - V. 8, №1. - P. 55-62.

Grunewald J. Sarcoidosis //Nat. Rev. Dis. Prim. - 2019. - V. 5, №1. - P. 45.

Hena K. M. Clinical Course of Sarcoidosis in World Trade Center-Exposed Firefighters //Chest. - 2018. - V. 153, №1. - P. 114-123.

Iannuzzi M. C. Genome-wide search for sarcoidosis susceptibility genes in African Americans //Genes Immun. - 2005. - V. 6, №6. - P. 509-518.

Jonsson E. Silica dust and sarcoidosis in Swedish construction workers /E. Jonsson, B. Jarvholm, M. Andersson //Occup. Med. (Chic. Ill). -2019. - V. 69, №7. - P. 482-486.

Llanos O H. N. Sarcoidosis //Med. Clin. North Am. - 2019. - V. 103, №3. - P. 527-534.

Mirsaeidi M. Racial Difference in Sarcoidosis Mortality in the United States //Chest. -2015. - V. 147, №2. - P. 438-449.

Muller-Quernheim J. Pathogenesis of sarcoidosis /J. Muller-Quernheim, A. Prasse, G. Zissel //Presse Med. - 2012. - V. 41. - P. 275-287.

Park J. E. Prevalence, incidence, and mortality of sarcoidosis in Korea, 2003-2015: A nationwide population-based study //Respir. Med. -2018. - Т. 144. - P. 28-34.

Ramos-Casals M. How the Frequency and Phenotype of Sarcoidosis is Driven by Environmental Determinants //Lung. - 2019. - V. 197, №4. - P. 427-436.

Rossman M. D. HLA-DRB1*1101: A Significant Risk Factor for Sarcoidosis in Blacks and Whites //Am. J. Hum. Genet. - 2003. - V. 73, №4. - P. 720-735.

Roszkiewicz J. Kaleidoscope of autoimmune diseases in HIV infection /J. Roszkiewicz, E. Smolewska //Rheumatol. Int. - 2016. - V. 36, №11. - P. 1481-1491.

Rybicki B. A. The BTNL2 gene and sarcoidosis susceptibility in African Americans and whites //Am. J. Hum. Genet. - 2005. - Т. 77, №3. - P. 491-499.

Rybicki B. A. The major histocompatibility complex gene region and sarcoidosis susceptibility in African Americans //Am. J. Respir. Crit. Care Med. - 2003. - V. 167, №3. - P. 444-449.

Salah S. Sarcoidosis //J. Fr. Ophtalmol. -2018. - V. 41, №10. - P. 451-467.

Sato H. HLA-DQB1*0201: A marker for good prognosis in British and Dutch patients with sarcoidosis //Am. J. Respir. Cell Mol. Biol. - 2002. -V. 27, №4. - P. 406-412.

Sawahata M. Age-related and historical changes in the clinical characteristics of sarcoidosis in Japan //Respir. Med. - 2015. - V. 109, №2. - P. 272-278.

Soto-Gomez N. Diagnosis and Management of Sarcoidosis /N. Soto-Gomez, J. I. Peters, A. M. Nambiar //Sarcoidosis. - 2016. - V. 1. -P. 11.

Spagnolo P., Grunewald J. Recent advances in the genetics of sarcoidosis //J. Med. Genet. - 2013. - V. 50, №5. - P. 290-297.

Suzuki H. Genetic Characterization and Susceptibility for Sarcoidosis in Japanese Patients: Risk Factors of BTNL2 Gene Polymorphisms and HLA Class II Alleles //Investig. Opthalmology Vis. Sci. - 2012. - V. 53, №11. - P. 7109.

Terwiel M. Clinical epidemiology of familial sarcoidosis: A systematic literature review /M. Terwiel, C. H. M. Moorsel //Respir. Med. - 2019. -V. 149. - P. 36-41.

Tussupbekova M. M. Diagnostic difficulties of lungs sarcoidosis /M. M. Tussupbekova, R. A. Bakenova, L. M. Stabayeva //Вестник КазН-МУ. - 2019. - №1. - P. 284-288.

Ungprasert P. Clinical Manifestations, Diagnosis, and Treatment of Sarcoidosis /P. Ungprasert, J. H. Ryu, E. L. Matteson //Mayo Clin. Proc. Innov. Qual. Outcomes. - 2019. - V. 3, №3. - P. 358-375.

Ungprasert P. Epidemiology and clinical characteristics of sarcoidosis: An update from a population-based cohort study from olmsted county, minnesota /P. Ungprasert, C. S. Crowson, E. L. Matteson //Reumatismo. - 2017. - V. 69, №1. - P. 16-22.

Ungprasert P. Influence of Gender on Epidemiology and Clinical Manifestations of Sarcoidosis: A Population-Based Retrospective Cohort Study 1976-2013 /P. Ungprasert, C. S. Crowson, E. L. Matteson //Lung. - 2017. - V. 195, №1. - P. 87-91.

Ungprasert P. Seasonal variation in incidence of sarcoidosis: A population-based study, 1976-2013 /P. Ungprasert, C. S. Crowson, E. L. Matteson //Thorax. - 2016. - V. 71, №12. -P. 1164-1166.

Ungprasert P. Smoking, obesity and risk of sarcoidosis: A population-based nested case-control study /P. Ungprasert, C. S. Crowson, E. L. Matteson // Respir. Med. - 2016. - V. 120. - P. 87-90.

Valeyre D. Sarcoidosis //Lancet. -2014. - V. 383, №9923. - С. 1155-1167.

Vizel A. A. Epidemiology of Sarcoidosis in the Russian Federation /A. A. Vizel, I. Y. Vizel, N. B. Amirov //Bull. Contemp. Clin. Med. - 2017. -V. 10, №5. - P. 66-73.

Webber M. P. Post-9/11 sarcoidosis in WTC-exposed firefighters and emergency medical service workers //Int. J. Environ. Res. Public Health. - 2019. - V. 16 (10). - P. 1727.

Wilsher M. L. Characteristics of sarcoidosis in Maori and Pacific Islanders // Respirology. - 2017. - V. 22, №2. - P. 360-363.

Wu C.-H. Comorbid autoimmune diseases in patients with sarcoidosis: A nationwide case-control study in Taiwan //J. Dermatol. -2017. - V. 44, №4. - P. 423-430.

The authors declare that there are no conflicts of interest present.